Abstract

A study of the urinary excretion of digitoxin in man was first attempted by Friedman and coworkers (1) by the use of the embryonic duck heart method of biological assay. These workers estimated that the amount of cardioactive substances (calculated as digitoxin) excreted in the urine of young adults over a period of 12 to 24 days after an oral dose was equivalent to approximately 40 per cent of the dose. However, no differentiation between digitoxin and possible cardioactive metabolites was attempted in this work. By using biosynthetically labeled C14-digitoxin, Okita et al. (2) found that 60 to 80 per cent of an intravenous dose was eliminated through the kidneys of humans over a long period, and that only 6 to 10 per cent of this appeared to be unchanged glycoside. The nature of the metabolites of the glycoside present in the urine was not investigated. Some qualitative information has been obtained about the metabolic products of cardiac glycosides excreted in rat urine (3, 4). Digoxin and lanatoside C were both excreted in this animal, principally as the unchanged glycoside, but both were also converted to a metabolic product which has been designated Metabolite B. Investigation into the chemical nature of this substance (5) indicated that it was probably a conjugate of the aglycone digoxigenin. Digitoxin was excreted in only small amounts as the unchanged glycoside in this animal (4); the principal urinary product was a substance, Metabolite C, which was thought to be a conjugate of a derivative of digitoxigenin. With higher doses of digitoxin, other metabolites appeared in the urine, one of which was named Metabolite G. We have now been able to make a qualitative study of the cardioactive substances present in human urine after oral administration of digoxin, digitoxin, and lanatoside C and have compared the metabolites present with those found in rat urine. A preliminary communication (6) outlined evidence which indicated that hydroxylation occurred at C-12 in the digitoxin molecule in humans and in rats, thereby producing a urinary metabolite which could not be separated from the glycoside digoxin. This evidence was based on experiments in which paper chromatography and C14-digitoxin were used, and the details of this work are also presented in this paper.

Highlights

  • Lanatoside C-A total of 12 mg. of lanatoside C was administered to twelve subjects and the pooled 12 hour urine collections were treated by the method described

  • Lanatoside C could not be detected in eluates by this method, owing to the retention of this glycoside on the water partition column

  • It is apparent that the metabolism of the cardiac glycosides digoxin, digitoxin, and lanatoside C is qualitatively similar in rats and in humans

Read more

Summary

Methods

Extraction of Glycosides and Metabolites from Human Urine--Healthy adults were given oral doses of 1 mg. of each glycoside and the 12 hour urine collections were pooled. Extraction of Glycosides and Metabolites from Human Urine--Healthy adults were given oral doses of 1 mg. Of each glycoside and the 12 hour urine collections were pooled. The pooled urine was treated with 40 per cent lead acetate solution until no further precipitation occurred. The precipitate was removed by centrifuging and the supernatant liquid was extracted by rolling approximately 200 ml. The chloroform extract was too heavily pigmented to allow direct application to paper chromatograms, and the following procedure was necessary to remove the bulk of the pigment. The chloroform extract was evaporated to small bulk under reduced pressure, absorbed on 250 mg. Of Super-Cel and packed into a column 8 mm. In diameter, filled with water-saturated benzene, and allowed to equilibrate with this solvent A partition column was prepared by adding 1 gm. of water to 1 gm. of Super-Cel and packed into a column 8 mm. in diameter, filled with water-saturated benzene, and allowed to equilibrate with this solvent

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call